Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: The pediatric experience

Pediatric Infectious Disease Journal

Volumn 20, Issue 8, 2001, Pages 733-740

  Neuzil, Kathleen M ^a   Dupont, William D ^b   Wright, Peter F ^b   Edwards, Kathryn M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trial; Influenza vaccine; Pediatrics

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION;

EID: 0034890537     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200108000-00004     Document Type: Article

References (31)

1. Mortality from influenza
2. Epidemiologic studies of Asian influenza in a Louisiana parish
3. Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: Comparison to age-specific infection rates, 1978-1979
4. Differing virulence of H1N1 and H3N2 influenza strains
5. The impact of influenza on hospitalizations, outpatient visits, and antibiotic prescriptions in children
6. Influenza and the rates of hospitalization for respiratory disease among infants and young children
7. The burden of influenza illness in children with asthma and other chronic medical conditions
8. Influenzavirus infections in Seattle families, 1975-1979
9. Estimating household and community transmission parameters for influenza
10. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts
11. Interpandemic influenza in the Houston area, 1974-76
12. Is it time to give influenza vaccine to healthy infants?
13. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease
14. Orthomyxoviruses
15. Prevention and control of influenza
16. Comparison of different approaches to measuring influenza A virus-specific hemagglutination inhibition antibodies in the presence of serum inhibitors
17. Comparison of 13 acellular pertussis vaccines: Adverse reactions
18. Immunogenicity and safety of 7-valent pneumococcal-CRM197 conjugate vaccine
19. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children: A multicentered evaluation of dosage and safety
20. Trials of influenza A/New Jersey/76 virus vaccine in normal children: An overview of age-related antigenicity and reactogenicity
21. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B
22. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses
23. Controlled trial of inactivated influenza vaccine containing the A/Hong Kong strain during an outbreak of influenza due to the A/England]42/72 strain
24. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital
25. Influenza vaccination in the prevention of acute otitis media in children
26. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care
27. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
28. Efficacy of vaccination with live-attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine